Woodside, CA – According to filings with the U.S. Securities and Exchange Commission, Empirical Spine is raising $16,381,583.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Richard Treadwell played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Empirical Spine
Our mission: Provide patients with a unique spinal stabilization system as an alternative to fusion, delivering better clinical outcomes for lower overall healthcare costs. The concept for the LimiFlex Paraspinous Tension Band was first invented by company co-founders Louie Fielding and Todd Alamin, MD in the Stanford University Biodesign Innovation program. The LimiFlex Paraspinous Tension Band was designed to provide stabilization without compromising spinal function, for patients with degenerative lumbar spinal disorders requiring segmental stabilization for which the current standard surgical option is spinal fusion. After receiving the CE mark in 2009, the LimiFlex Paraspinous Tension Band was used to treat more than 2,000 patients, primarily in Europe. A clinical trial has been approved by the United States FDA under an Investigational Device Exemption (IDE) to study use of LimiFlex in patients with lumbar spinal stenosis with up to Grade I degenerative spondylolisthesis.

To learn more about Empirical Spine, visit http://limiflex.com/

Contact:
Richard Treadwell, President and Chief Executive Officer
650-585-6307
rtreadwell@limiflex.com
https://www.linkedin.com/in/richardtreadwell/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved